ZKSCAN2-DT
gene geneOn this page
Also known as CTD-2547G23.4
Summary
ZKSCAN2-DT (ZKSCAN2 divergent transcript, HGNC:53912) is a long non-coding RNA gene on chromosome 16p12.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53912 |
| Approved symbol | ZKSCAN2-DT |
| Name | ZKSCAN2 divergent transcript |
| Location | 16p12.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | CTD-2547G23.4 |
| Ensembl gene | ENSG00000274925 |
| Ensembl biotype | lncRNA |
| Entrez | 112577464 |
| RNAcentral | URS0002123142 — lncRNA, 3490 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000612792, ENST00000819917, ENST00000819918, ENST00000819919
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000612792 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003718143 | 25257952 | 25261066 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 76.55.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2270 / max 89.2489, expressed in 1029 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 153275 | 2.2270 | 1029 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 76.55 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.49 | silver quality |
| right uterine tube | UBERON:0001302 | 73.18 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.66 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.54 | gold quality |
| body of uterus | UBERON:0009853 | 70.70 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 70.64 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.28 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.20 | silver quality |
| thyroid gland | UBERON:0002046 | 70.19 | gold quality |
| left ovary | UBERON:0002119 | 70.12 | gold quality |
| right ovary | UBERON:0002118 | 69.87 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.85 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 69.66 | gold quality |
| cerebellar cortex | UBERON:0002129 | 69.55 | gold quality |
| gastrocnemius | UBERON:0001388 | 69.47 | gold quality |
| bone marrow cell | CL:0002092 | 69.17 | silver quality |
| endocervix | UBERON:0000458 | 69.04 | gold quality |
| spleen | UBERON:0002106 | 68.76 | gold quality |
| muscle of leg | UBERON:0001383 | 68.73 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 68.60 | gold quality |
| cerebellum | UBERON:0002037 | 68.52 | gold quality |
| pituitary gland | UBERON:0000007 | 68.46 | gold quality |
| right coronary artery | UBERON:0001625 | 68.27 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 68.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 67.83 | gold quality |
| minor salivary gland | UBERON:0001830 | 67.71 | gold quality |
| transverse colon | UBERON:0001157 | 67.57 | gold quality |
| cortex of kidney | UBERON:0001225 | 67.37 | gold quality |
| stromal cell of endometrium | CL:0002255 | 67.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.20 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.